Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis.

Naunyn Schmiedebergs Arch Pharmacol · 2024 · PMC11074217 · PMID 37966571

Europe PMC DOI

hedged sentence

0.3495

closest p · 7.0× alpha

0.3495

boldest claim

The sentences

did not reach statistical significancep = 0.3495not close (p > 0.1)

However, the difference in PFS did not reach statistical significance ( p = 0.3495) (Saghatelyan et al. 2020 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.